Trade Tracker: Amy Raskin shares her latest portfolio moves

All right, I told you Amy Rascinet had some news uh moves, excuse me. Well, kind of news. Let's go through that.Uh, Ascendus Pharma is a new buy as D. Tell me more. >> Um, it's a 12 billion Danish biotech company.Um, it reached profitability this last quarter. It's had a nice run. Um, year-to- date it's up about 50%.But and we think it has a really interesting technology which extends the half-life of drugs which obviously improves the effic efficacy and safety of drugs and um they can license out to other ...